N
PLRX icon

Nuveen’s Pliant Therapeutics PLRX Stock Holding History

Nuveen’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-233,585
Closed -$635K – 3373
2025
Q1 		$635K Buy
233,585
+26,638
+13% +$162K ﹤0.01% 2824
2024
Q4 		$2.73M Sell
206,947
-128,533
-38% -$1.75M ﹤0.01% 2253
2024
Q3 		$14.7M Buy
335,480
+142,351
+74% +$1.78M ﹤0.01% 1379
2024
Q2 		$2.08M Sell
193,129
-18,801
-9% -$242K ﹤0.01% 2377
2024
Q1 		$3.16M Buy
211,930
+21,194
+11% +$350K ﹤0.01% 2182
2023
Q4 		$3.45M Sell
190,736
-18,807
-9% -$286K ﹤0.01% 2153
2023
Q3 		$3.63M Buy
209,543
+655
+0.3% +$11.4K ﹤0.01% 2027
2023
Q2 		$3.79M Buy
208,888
+160,728
+334% +$3.8M ﹤0.01% 2056
2023
Q1 		$1.28M Buy
48,160
+4,938
+11% +$141K ﹤0.01% 2513
2022
Q4 		$835K Buy
+43,222
New +$904K ﹤0.01% 2751
2022
Q2 		– Sell
-81,824
Closed -$619K – 3436
2022
Q1 		$619K Sell
81,824
-7,122
-8% -$72.7K ﹤0.01% 2952
2021
Q4 		$1.2M Sell
88,946
-4,180
-4% -$66.4K ﹤0.01% 2794
2021
Q3 		$1.57M Sell
93,126
-16,811
-15% -$357K ﹤0.01% 2787
2021
Q2 		$3.2M Buy
109,937
+29,660
+37% +$923K ﹤0.01% 2482
2021
Q1 		$3.16M Buy
80,277
+57,172
+247% +$1.86M ﹤0.01% 2397
2020
Q4 		$525K Hold
23,105
– – ﹤0.01% 3032
2020
Q3 		$523K Buy
+23,105
New +$577K ﹤0.01% 2941

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Nuveen's PLRX Position: Q2 2025 in Review

Nuveen sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 233,585 shares — an estimated $635K sold.

Nuveen first reported a position in PLRX in Q3 2020 and held it in 17 quarters. The position peaked at $14.7M in Q3 2024. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Nuveen reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 233,585 Pliant Therapeutics shares in Q2 2025, an estimated $635K.
  • Nuveen first reported a position in Pliant Therapeutics in Q3 2020 and held it in 17 quarters.
  • Nuveen's Pliant Therapeutics position peaked at $14.7M in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.